Zydus Lifesciences Publishes Official Notice for 'Saksham Niveshak' Campaign
Zydus Lifesciences has published the official notice for its second 100-day 'Saksham Niveshak' campaign in Financial Express and communicated the publication to BSE and NSE. The campaign runs from April 1-July 9, 2026, targeting shareholders with unpaid dividends and encouraging KYC updates to prevent IEPF transfer.
*this image is generated using AI for illustrative purposes only.
Zydus life science has officially published its notice for the second 100-day investor awareness campaign titled 'Saksham Niveshak' in Financial Express on April 22, 2026. The pharmaceutical company simultaneously communicated this publication to both major stock exchanges, demonstrating compliance with regulatory disclosure requirements.
Official Publication and Exchange Communication
The company published the campaign notice in both English and Gujarati editions of Financial Express on April 22, 2026. Zydus Lifesciences promptly informed the listing departments of BSE Limited and National Stock Exchange of India Limited about this newspaper publication through official correspondence.
| Exchange Details: | Information |
|---|---|
| BSE Code: | 532321 |
| NSE Code: | Zyduslife |
| Publication Date: | April 22, 2026 |
| Languages: | English and Gujarati |
| Newspaper: | Financial Express |
Campaign Overview and Timeline
The 'Saksham Niveshak' campaign, launched following directives from the Investor Education and Protection Fund Authority (IEPFA), commenced on April 1, 2026, and will continue until July 9, 2026. This initiative specifically targets shareholders whose dividends have remained unpaid or unclaimed, forming part of IEPFA's broader drive for investor education and facilitation.
| Campaign Parameter: | Details |
|---|---|
| Campaign Name: | Saksham Niveshak |
| Duration: | April 1, 2026 to July 9, 2026 |
| Total Days: | 100 days |
| Target Audience: | Shareholders with unpaid/unclaimed dividends |
| Authority: | IEPFA directive |
Shareholder Action Requirements
The campaign addresses shareholders who need to update their Know Your Customer (KYC) and nomination details or have issues related to unpaid dividends and shares. Shareholders requiring assistance can contact the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India Private Limited), located at 5th Floor, 506 to 508, Amarnath Business Centre – I (ABC-I), Besides Gala Business Centre, Off C. G. Road, Ellisbridge, Ahmedabad-380006.
Contact Information and Accessibility
For direct communication, shareholders can reach the company's Nodal Officer at companysecretary@zyduslife.com or contact the Registrar at telephone numbers 079-26465179/86/87 and email ahmedabad@in.mpms.mufg.com . The notice, signed by Dhaval N. Soni, Company Secretary and Compliance Officer (Membership No. FCS7063), is available on the company website at www.zyduslife.com and stock exchange websites at www.nseindia.com and www.bseindia.com .
The bilingual publication approach ensures maximum reach among shareholders across different linguistic backgrounds, emphasizing the company's commitment to inclusive communication and regulatory compliance in preventing shares from being transferred to the IEPF.
Historical Stock Returns for Zydus Life Science
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.32% | -0.46% | +6.01% | -6.49% | +6.75% | +64.98% |
What percentage of Zydus Lifesciences' total shareholders are affected by unpaid dividends, and how might this impact the company's investor relations strategy?
Will the success of this 100-day campaign influence IEPFA to mandate similar investor awareness initiatives across other pharmaceutical companies?
How could the resolution of unclaimed dividends and updated KYC compliance affect Zydus Lifesciences' share price and trading volumes in the coming quarters?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
